68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors — Stella

Home/Breast Neoplasms、Lung Neoplasms、Pancreatic Neoplasms/

View on ClinicalTrials.gov

Recruiting

Back to Breast Neoplasms、Lung Neoplasms、Pancreatic Neoplasms trials

Trial locations(1 site)

China

Peking university first hospital nuclear medicine, Beijing, Beijing Municipality

Key details

Sponsor

Peking University First Hospital

Enrollment target

~10 participants

Started

June 2025

Primary completion

October 2027

Age range

18 Years – 80 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.